Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Statement [Line Items]
Beginning balance	$ 211,539	$ 95,181
Issuance of common stock, net of issuance costs	80,804	182,857
Issuance of common stock under employee benefit plans	3,519	3,668
Vesting of restricted stock awards	$ 1	$ 5
Vesting of restricted stock awards, Shares	76,718	0
Stock-based compensation expense	$ 13,350	$ 11,070
Unrealized loss on marketable securities	(400)	(395)
Net loss	(109,871)	(80,847)
Ending balance	198,942	211,539
Common Stock
Statement [Line Items]
Beginning balance	$ 41	$ 28
Beginning balance, Shares	40,626,224	27,941,566
Issuance of common stock, net of issuance costs	$ 11	$ 12
Issuance of common stock, Shares	11,029,410	12,190,000
Issuance of common stock under employee benefit plans		$ 1
Issuance of common stock under employee benefit plans, Shares	433,403	381,967
Vesting of restricted stock awards, Shares	10,174	112,691
Ending balance	$ 52	$ 41
Ending balance, Shares	52,099,211	40,626,224
Treasury Stock
Statement [Line Items]
Repurchase of unvested restricted stock awards		2,971
Retirement of treasury shares		(2,971)
Additional Paid-In Capital
Statement [Line Items]
Beginning balance	$ 514,362	$ 316,775
Issuance of common stock, net of issuance costs	80,793	182,845
Issuance of common stock under employee benefit plans	3,519	3,667
Vesting of restricted stock awards	1	5
Stock-based compensation expense	13,350	11,070
Ending balance	612,025	514,362
Accumulated other comprehensive loss
Statement [Line Items]
Beginning balance	(397)	(2)
Unrealized loss on marketable securities	(400)	(395)
Ending balance	(797)	(397)
Accumulated Deficit
Statement [Line Items]
Beginning balance	(302,467)	(221,620)
Net loss	(109,871)	(80,847)
Ending balance	$ (412,338)	$ (302,467)